Callan Family Office’s argenx ARGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.89M Buy
2,035
+58
+3% +$47.8K 0.04% 410
2026
Q1
$1.44M Hold
1,977
0.03% 452
2025
Q4
$1.66M Buy
1,977
+619
+46% +$530K 0.04% 395
2025
Q3
$1M Sell
1,358
-94
-6% -$62K 0.03% 373
2025
Q2
$800K Buy
1,452
+1,090
+301% +$633K 0.03% 450
2025
Q1
$214K Sell
362
-282
-44% -$178K 0.02% 511
2024
Q4
$396K Buy
+644
New +$377K 0.03% 421

Other funds holding ARGX

Callan Family Office's ARGX Position: Q2 2026 in Review

Callan Family Office increased its argenx (ARGX) stake by 2.9% in Q2 2026, buying an estimated $47.8K and bringing the position to 2,035 shares worth $1.89M. The position accounts for 0.04% of the portfolio, ranked #410.

Callan Family Office first reported a position in ARGX in Q4 2024 and has held it in 7 quarters since. 506 funds tracked by Wall St. Rank hold ARGX as of Q2 2026.

  • Callan Family Office held 2,035 shares of argenx worth $1.89M as of Q2 2026.
  • Callan Family Office bought 58 argenx shares in Q2 2026, an estimated $47.8K.
  • argenx made up 0.04% of Callan Family Office's portfolio in Q2 2026, its #410 holding.
  • Callan Family Office first reported a position in argenx in Q4 2024 and has held it in 7 quarters since.
  • 506 funds tracked by Wall St. Rank held argenx as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.